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Background: The optimal treatment of osteonecrosis of the femoral head has not been established yet. The aim of
this study was to report preliminary clinical results of focal anatomic-resurfacing implantation for the treatment of
osteonecrosis of the femoral head.
Methods: Five patients (four male, one female) with seven surgical procedures, ages between 37 and 52 with an
average age of 45.2 (+/− 7.2), diagnosed as femoral head avascular necrosis and who were unresponsive to
conservative management or had failed previous surgical treatments were treated with a focal anatomic femoral
head resurfacing between the years 2011–2012 and were retrospectively reviewed. Five patients with at least two
years of follow-up, one left hip, two right hips, and two patients with bilateral hip surgery were included in this
review. After safe surgical dislocation of the hip, full exposure of the femoral head was established. A focal-
resurfacing implant matching patient anatomy and femoral head curvature was performed accordingly. Neither
intraoperative or postoperative complications nor revision ensued. Visual analogue scores and Harris Hip Scores
were recorded both preoperatively and at postoperative 2 years for all seven surgeries.
Results: The mean follow-up period was 26.6 +/− 3.8 months, with a range between 24–33 months. The mean visual
analogue scores were 8.9 +/− 0.9 preoperatively and 2.3 +/− 1.0 postoperatively at year two (p = 0.017). Harris Hip Scores
at postoperative follow-up were found to improve significantly from good to excellent scores (86.0 +/− 7.9), compared
with preoperative poor scores (26.7 +/− 11.8) (p = 0.018). The clinical improvements in visual analogue scores (VAS) and
Harris Hip Scores were also found to correlate with each other (p< 0.05).
Conclusions: In the present study, the alternative technique of focal anatomic hip resurfacing with HemiCAP® yielded
preliminary successful results for the treatment of osteonecrosis of the femoral head. To the best of our knowledge, this is
the first case series in the literature, reporting functional clinical results with the use of a focal anatomic-resurfacing
implant for the treatment of focal femoral head osteonecrosis.
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Osteonecrosis (ON) of the femoral head is a painful,
progressive, and potentially debilitating disease, which
affects patients in their third to fifth decades of life
[1-3]. A variety of risk factors have been identified in the
literature including trauma, alcohol abuse, chronic cor-
ticosteroid use, and coagulation disorders [4]. Although
ischemia, direct cellular toxicity and altered differentiation
of mesenchymal stem cells were postulated mechanisms
of pathogenesis, the exact etiology and pathogenesis are
still not certain [3,5].
Early diagnosis before collapse occurs is important in
order to prevent subsequent collapse and osteoarthritis.
The diagnosis requires a high index of suspicion, espe-
cially in the earliest stages. Deep groin pain is the most
common early symptom. Limitation of range of motion
(ROM) (especially internal rotation) is mostly evident at
later stages. In general, the diagnosis is made by radiog-
raphy and magnetic resonance imaging (MRI). MRI
seems to be the best diagnostic tool with the highest
sensitivity and specificity [6,7]. Moreover, MRI is the
mainstay of all classification systems to stage ON, which
currently guide treatment decisions and have prognostic
importance. The two most commonly used classification
systems are Ficat & Arlet, Ficat and Steinberg University
of Pennsylvania [8-11]. The extent of the necrotic
portion of the femoral head, which was also found to be
a prognostic factor for collapse, could be measured with
modified Kerboul method [12].
The treatment has been mostly based on the stage,
extent, location, and cause of the ON together with the
age of the patient. Currently, there are two main ap-
proaches for treatment: non-operative and operative.
Both aim to relieve pain, to improve function, and to
prevent progression to some extent. A variety of modal-
ities have been described for the non-operative manage-
ment of hip osteonecrosis in the literature including non-
weight bearing, non-steroidal anti-inflammatory drugs,Table 1 Demographic features of patients
Patient number Age Sex Previous managements
1 48 Male Conservative
2 51 Female Conservative, core decompress
3 37 Male Conservative, core decompress
4 52 Male Conservative, core decompress
5 38 Male Conservative
R: Right, L: Left, ITP: Idiopathic Thrombocytopenic Purpura.extra-corporeal shock wave treatment, pulsed electro-
magnetic therapy, and hyperbaric oxygen [13-21]. Many
of these conservative treatments may only have a role in
the early pre-collapse stages of the disease, with question-
able limited success.
Currently, surgical treatment of ON of the femoral
head includes the following: percutaneous drilling, core
decompression with or without bone grafting, biological
additions (stem cells, platelet rich plasma etc.), vascular-
ized bone grafting, tantalum rods, proximal femoral
osteotomies, and hip arthroplasties [22-32]. Although it
seems that the most promising results were obtained
with total hip arthroplasty, the optimal treatment for
ON of the femoral head has not yet been established
especially in young and middle-aged people [3,4].
The aim of this study was to report preliminary
clinical outcomes of focal resurfacing implantation for
ON of the femoral head as an alternative option of joint-
preserving surgery of the hip. To the best of our knowledge,
this is the first case series regarding the use of an alternative




This study comprised a retrospective review of prospect-
ively collected data for seven hips of five patients (four
male, one female). The average age of the patients was
45.2 years (range 37–52 years). The demographic
features of the patients are presented in Table 1. All
patients presented with severe hip pain and limitation in
hip ROM. The patients were diagnosed as Ficat-Arlet
stage IIB, III, or IV femoral head avascular necrosis (two
hips IIB, four hips III, one hip IV). Radiological imaging
with X-ray and MRI of a patient with bilateral osteo-
necrosis of femoral head are shown in Figures 1 and 2.
All the patients were unresponsive to non-surgical
methods for at least one year. Two patients had previousRisk factors Surgical side Ficat-Arlet stage
Hodgkin’s Lymphoma R III
Steroid use L III
ion Breast cancer R IIB
Radiotherapy
Steroid use
ion ITP L III
Steroid use R IV
ion Bronchial asthma R III
Steroid use
Alcohol abuse R IIB
Figure 1 Preoperative X-ray. Anteroposterior pelvis X-ray
demonstrating bilateral ON of the femoral head.
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formed consent for surgery, patients were informed that
the data would be reviewed for research. This study was
also approved by the local Medical Ethics Committee.
Surgical technique
Informed consent was obtained from all patients dis-
cussing risks and complications including the possibility
of conversion to total hip arthroplasty in the case of
poor bone quality or fracture. None of the cases had to
have a total hip arthroplasty. The seven surgeries were
performed with the standard technique with a lateral ap-
proach and trochanteric flip osteotomy. Following peri-
operative prophylaxis with antibiotics and identification
of the correct extremity, patients had spinal anesthesia
and were placed in a lateral decubitus position. TheFigure 2 Preoperative MRI scan. T1-weighted coronal MRI scan
demonstrating bilateral ON of the femoral head.surgical site was prepared and draped in a standardized
sterile manner. Surgical dislocation of the hip was per-
formed following a direct lateral approach to the hip and
trochanteric flip osteotomy as described by Ganz et al.
[33]. The hip was dislocated anteriorly with full vision of
the femoral head and neck.
Firstly, the borders of the affected softened cartilage
overlying the focal osteonecrotic area were determined.
A femoral head osteoplasty was performed if necessary
due to impingement. Then, a K-wire is passed through
the sizing jig covering the entire lesion, into the center
of the predetermined osteonecrotic area. After the de-
bridement of this area by using a power drill over the
guide K-wire, with simultaneous lavage, the tapered ti-
tanium screw was inserted securely by the screwdriver,
following a proper taping over the guide K-wire. A con-
tact probe was used in order to size the medial, lateral,
anterior, and posterior contours correctly. There are
seven different offset sizes available. After the final trial
and surface reaming, an anatomically fit sized, 35 mm
diameters, final implant was fixed on the pre-implanted
titanium screw - approximately 0.5 mm below the per-
ipheral healthy articular cartilage surface - with slight
tapping with a mallet via an interlocking mechanism.
The intraoperative fluoroscopic view was imperative in
all cases to see the properly placed focal-resurfacing im-
plant matching the patient’s anatomy and femoral head
curvature (HemiCAP®, Arthrosurface, Franklin, MA)
with preservation of the joint space after gentle reduc-
tion of the joint. Finally the trochanteric osteotomy was
repaired with two 4.5-mm cortical screws. Neither peri-
operative nor intraoperative complications ensued in any
patients (Figures 3, 4, 5, and 6).
It was imperative that good screw fixation was
achieved for solid fixation of the implant. In each case,
the screw was well fixed and often was difficult to turn
into the underlying bone. In no instance was there any
concern for fixation. We were prepared to utilize cement
if necessary to augment fixation of the screw but this
was not necessary.
Postoperative management
Prophylactic antibiotic, which had been started perio-
peratively, was continued for 24 hours. Thromboprophy-
laxis with third generation low molecular weight heparin
(Bemiparin, Hibor™) was started postoperatively at 12 hours
and continued for 6 weeks. Neither early nor late postop-
erative complications ensued. The patients were mobilized
with toe-touch weight bearing during the first four weeks,
allowing the osteotomized greater trochanter to heal and
sufficient implant-bone integration. Thereafter, the mobi-
lization was progressed from partial to full-weight bearing.
The osteotomies were healed at two months postopera-
tively. The screws were removed in two patients, as they
Figure 3 Surgical step 1. Following determination of the borders of the affected softened cartilage overlying osteonecrotic area and femoral
head osteoplasty (if necessary due to impingement), a K-wire is passed through the sizing jig, into the center of the predetermined osteonecrotic
area, which was debrided by using a power drill, with simultaneous lavage.
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daily activities at a mean of three months postoperatively.
At final radiological reviews, neither loosening nor subsid-
ence of the implants were observed (Figures 7 and 8).
Moreover, no progression of the osteonecrosis, acetabular
reaction, head collapse, and progression to osteoarthritis
were observed.
Evaluation criteria
The clinical evaluation of the patients was done by using
visual analogue score (VAS) and Harris Hip Score
(HHS). These scores were recorded both preoperatively
and at postoperative 2 years, for all seven surgeries of
five patients. The data were retrospectively reviewed.
Statistical methods
SPSS version 16.0 was used for statistics. Statistical ana-
lyses were performed using the Wilcoxon test and
Spearman correlation test, for comparison between pre-
operative and postoperative values and for correlation of
VAS and Harris Hip scores, respectively. The statistical
significance was determined at p value <0.05.Figure 4 Surgical step 2. Implantation of the tapered titanium screw secur
sizing of the medial, lateral, anterior, and posterior contours with the contaResults
The mean follow-up period was 26.6 +/− 3.8 months (range
24–33 months). The mean VAS scores were 8.9 +/− 0.9
preoperatively and 2.3 +/− 1.0 postoperatively at year two
(p = 0.017). Harris Hip Scores improved from 26.7 pre-
operatively to 86.0 postoperatively, which were in the good
to excellent category (p = 0.018). The data were summa-
rized in Table 2 and Figure 9. The preoperative mean
scores for pain, functional status, and joint status were
13.6 +/− 5.6, 10.3 +/− 6.6, and 2.9 +/− 1.3, respectively.
The respective values at postoperative 2nd years were
45.0 +/− 5.2, 32.3 +/− 4.8, and 8.9 +/− 0.7. The lowest
items having the poorest scores postoperatively were
found to be the following: support, distance walked,
and sitting. In addition, the improvements in VAS and
Harris Hip Scores were found to correlate significantly
with each other (p < 0.05).
Discussion
The most important result of this study was that the use
of the focal anatomic-resurfacing implant for the treat-
ment of osteonecrosis of the femoral head yieldedely by the screwdriver, after proper taping over the guide K-wire and
ct probe.
Figure 5 Surgical step 3. Placement of the anatomically fit sized, 35 mm diameter final implant with slight tapping with a mallet, after trialing
and surface reaming. Final view of tapered interlocked CoCrMo articular-resurfacing component, approximately 0.5 mm below the peripheral
healthy articular cartilage surface.
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five patients at a minimum of two years following their
surgical procedure. In addition, to the best of our know-
ledge, this study is the first case series related with the
use of this alternative focal anatomic-resurfacing implant
for this specific indication.
In general, the management of osteonecrosis of the fem-
oral head consists of non-surgical and surgical methods.
Non-surgical modalities such as non-weight bearing,
pharmacological (bisphosphonates, anticoagulants, lipid-
lowering agents, vasodilators), extra-corporeal shock wave
treatment, pulsed electromagnetic therapy, and hyper-
baric oxygen may have a role only in the early pre-Figure 6 Intraoperative fluoroscopic view. Intraoperative
fluoroscopic view showing a properly placed implant (HemiCAP®,
Arthrosurface, Franklin, MA) with preservation of the joint space after
reduction of the joint and final repair of the trochanteric osteotomy
with two 4.5-mm cortical screws.collapse stages of the disease, with a questionable limited
success [13-21].
Surgical methods can also be subdivided into two major
groups: joint preserving options and total hip arthroplasty.
Joint preserving options include the following: percutan-
eous drilling, core decompression with or without bone
grafting, biological procedures (bone marrow stimulation
or microfracture, mesenchymal stem cells), vascularized
bone grafting, tantalum rods, proximal femoral osteoto-
mies, and hip arthroplasties [22-32].
The most commonly performed surgical method is
probably core decompression, which aims to decrease
intraosseous pressure and to ameliorate the blood flow
to the necrotic area and subsequent healing by creeping
substitution. Despite these aims and its use at earlier
stages of the disease process, the rate of further add-
itional surgery requirements was reported as high as
80% [13,34,35]. The clinical results of this option had
wide variations from 0% to 91% [36]. Moreover, Lee
et al. found that intertrochanteric osseous pressure was
significantly higher after multiple drilling and that these
patients had poorer outcomes [37]. Interestingly, this re-
sult raises the question of whether the increase in pressure
in the intertrochanteric region after core decompression
increases the severity of the disease progression or not.
Another viable surgical option is free vascularized
bone grafting, which has been advised for earlier stages,
before collapse [3,35]. Although successful results were
reported at a longer term [27,38,39], it is a highly tech-
nical and demanding procedure and is associated with
significant donor site morbidities and progression of the
osteonecrotic lesion.
When there is a collapse of the lesion, treatment be-
comes more difficult. Although it seems that the most
promising results, especially at late stages, are reported
with total hip arthroplasty, the optimal surgical treatment
for ON of the femoral head has not been established,
Figure 7 Postoperative X-rays. X-rays at postoperative second years of a 48-year-old male patient. These radiographs show the preservation of
the joint spaces without loosening of the implants bilaterally. The screws were removed because of irritation in this patient.
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longevity of the implant and is a definite concern [40]. In
addition, in contrast to its successful use in patients with
primary coxarthrosis, THA was found to have a higher
rate of failure in patients with osteoarthritis secondary to
osteonecrosis [41,42]. Moreover, the results of THA were
reported to be poor in the young age group, which these
patients usually are [43-46]. In this context, the import-
ance of hip-preserving surgery has also been stressed in
the last decade recently [47]. Under the light of these find-
ings, an alternative treatment option is required in this
young age group. Although our study exhibited pre-
liminary results at a mean follow-up of postoperative
26 months, the early results were promising, and we an-
ticipate a better solution in young patients compared
with THA, with the advantage of postponing the age for
THA. As the number of selected younger patients - with
focal ON of the femoral head - who will be treated with
the hip HemiCAP® increase, the results will be easier to
compare with those of THA.
Recently, short-term successful results were obtained
with resurfacing arthroplasty in the treatment of osteo-
necrosis of the femoral head [48]. This procedure preserves
bone stock in the femoral head, without compromisingFigure 8 Postoperative X-rays. X-rays of a 37-year-old male patient at postsubsequent conversion to THA. It can also be used at
postcollapse stages in young patients with good bone
stock [3]. But, due to reported high revision rates to THA,
mostly because of femoral neck fracture, and due to ef-
fects of metallic wear debris, most surgeons do not prefer
resurfacing arthroplasty for the treatment of ON of the
femoral head [49-51].
Compared with previously discussed alternative tech-
niques, the hip HemiCAP® system has some advantages.
At first, preoperative planning is not as detailed as total
hip arthroplasty. It is a femoral head and joint-
preserving surgery in which the patient’s own femoral
head anatomy is protected to a maximal extent with lit-
tle bony resection and can be used even in cases of col-
lapse. After the entire exposure of the femoral head,
removal of the necrotic area is followed by replacement
of the defect by a two-part implant fixed in position with
a large threaded screw. This implant matches each pa-
tient’s anatomy and femoral head contour. They are suit-
able for young and middle-aged patients with focal
lesions. Another advantage is that in case of progression
of osteoarthritis, or implant failure or fracture at any
time, there is always a chance to revise to primary total
hip arthroplasty.operative 24th months.
Table 2 Preoperative and postoperative 2nd year VAS and Harris Hip Scores




1 R 10 2 24 84
L 8 1 51 94
2 R 8 2 22 88
3 R 10 3 15 87
L 9 2 22 86
4 R 8 2 32 93
5 R 9 4 21 70
Mean +/− SD 8.9 +/− 0.9 2.3 +/− 1.0 26.7 +/− 11.8 86.0 +/− 7.9
p values 0.017 0.018
VAS: visual analogue score, SD: standard deviation.
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ture to our knowledge of the use of HemiCAP® for
femoral head pathologies. In the first study, Jäger et al.
reported successful results in a 22-year-old female pa-
tient having traumatic osteonecrosis of the femoral
head, with one-year follow-up [52]. In a second study,
partial resurfacing was performed successfully following
a subcapital femoral varus osteotomy in a 16-year-old
male patient, with a two-year follow-up [53]. In a study
of Mahmud et al., a 24-year-old male with osteochon-
dral defect of the femoral head was successfully treated
with HemiCAP®, with five-years follow-up [54]. Re-
cently, a patient having an osteochondral lesion of the
hip, who was treated with partial femoral resurfacing,
has been reported with the longest follow-up of six
years [55].Figure 9 Mean VAS and Harris Hip Scores. Mean values (+/− SD, longitudin
(green bar) VAS and Harris Hip Scores (VAS = visual analogue score, HHS = HTo our knowledge, the present study is the first report
of a consecutive case series with the use of HemiCAP®
for the treatment of focal ON of the femoral head. But,
there are some limitations of this study, which should be
discussed. Firstly, this study compromises a small num-
ber of patients, but this is not a common condition and
large studies are difficult to do to collect enough cases.
Another limitation is the retrospective evaluation of the
prospectively collected data. A prospective, multi-center
study evaluating this procedure over a long term would
give more definitive results. However, the procedure
seems to have some promise in the treatment of osteo-
necrosis with advanced stages and collapse or as a sal-
vage of other failed procedures. The biggest advantage is
that the anatomy is preserved so that future procedures
are not compromised.al lines) of preoperative (purple bar) and postoperative second year
arris Hip Score, preop. = preoperative, postop. = postoperative).
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As a result, the optimal and ideal treatment for the focal
osteonecrosis of the femoral head has not been established,
especially for young and middle-aged patients. Although
THA is often used for these patients, implant longevity and
subsequent revisions have still been problems in these age
groups. To the best of our knowledge, this study is the first
case series in the literature, reporting successful clinical re-
sults with the use of an alternative focal, anatomic, limited-
resurfacing implant (HemiCAP®) for the femoral head and
joint preserving treatment of focal osteonecrosis, and we
would recommend it as a potential alternative treatment
option for these patients.
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